Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2024

12-12-2023 | Chronic Inflammatory Bowel Disease | Original Article

Knowledge Levels About Inflammatory Bowel Disease Vary Between Healthcare Professional Groups

Authors: Angharad Vernon-Roberts, Lucy Blay, Andrew S. Day

Published in: Digestive Diseases and Sciences | Issue 2/2024

Login to get access

Abstract

Background

Inflammatory Bowel Disease (IBD) is one of the most serious chronic diseases affecting the global population. Clinical team members involved in the care of individuals with IBD should have sufficient knowledge about IBD.

Aims

The study aim was to assess IBD knowledge among four health care professional groups in New Zealand: nurses, medical students, dietitians, and pharmacists.

Methods

All four groups completed surveys on demographics, work experience, and contact with patients with IBD. All completed a validated IBD knowledge assessment questionnaire (IBD-KID2), and percentage scores with standard deviation (SD) for each group calculated and compared.

Results

Participants included 200 nurses, 196 medical students, 45 dietitians, and 28 pharmacists. Mean IBD-KID2 percentage scores were nurses 69.7% (SD 14.7), medical students 77.6% (SD 14.5), dietitians 87.4% (SD 8.3), and pharmacists 83.4% (SD 10.1). Nurses scored lower than other HCP (P < 0.001). Independent variables were associated (P < 0.05) with higher scores for nurses having first degree relative with IBD, access to IBD guidelines, worked with children with IBD; medical students in their clinical years of study; and dietitians with IBD-specific education. Specific items scored poorly: growth, food triggers, heritability of IBD, and nutrient absorption.

Conclusions

Knowledge gaps exist among HCP that may be addressed with targeted education. Improvements in the knowledge of those caring for people with IBD may optimize patient outcomes.
Literature
1.
go back to reference Alatab S, Sepanlou SG, Ikuta K et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30.CrossRef Alatab S, Sepanlou SG, Ikuta K et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30.CrossRef
2.
go back to reference Kuenzig ME, Fung SG, Marderfeld L et al. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterol. 2022;162:1147–59.e4.CrossRef Kuenzig ME, Fung SG, Marderfeld L et al. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review. Gastroenterol. 2022;162:1147–59.e4.CrossRef
3.
go back to reference Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390:2769–2778.CrossRef Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390:2769–2778.CrossRef
4.
go back to reference van Deen WK, Obremskey A, Moore G, van den Akker-van Marle ME, Doctor JN, Hwang C. An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score. Qual Life Res. 2020;29:3387–3396.CrossRefPubMed van Deen WK, Obremskey A, Moore G, van den Akker-van Marle ME, Doctor JN, Hwang C. An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score. Qual Life Res. 2020;29:3387–3396.CrossRefPubMed
5.
go back to reference Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis. 2014;20:545–552.CrossRefPubMed Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis. 2014;20:545–552.CrossRefPubMed
6.
go back to reference Byrne G, Rosenfeld G, Leung Y et al. Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol. 2017;2017:6.CrossRef Byrne G, Rosenfeld G, Leung Y et al. Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease. Can J Gastroenterol Hepatol. 2017;2017:6.CrossRef
7.
go back to reference Park J, Yoon H, Shin CM, Park YS, Kim N, Dong Ho L. Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease. PLoS One. 2020;15. Park J, Yoon H, Shin CM, Park YS, Kim N, Dong Ho L. Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease. PLoS One. 2020;15.
8.
go back to reference Martinato M, Comoretto RI, Monaco E, Ocagli H, Gregori D. Disease knowledge and quality of life perception in Inflammatory Bowel Disease: a randomised controlled trial. J Crohns Colitis. 2022;16:i621-i. Martinato M, Comoretto RI, Monaco E, Ocagli H, Gregori D. Disease knowledge and quality of life perception in Inflammatory Bowel Disease: a randomised controlled trial. J Crohns Colitis. 2022;16:i621-i.
9.
go back to reference Moradkhani A, Kerwin L, Dudley-Brown S, Tabibian JH. Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease. Dig Dis Sci. 2011;56:2972–2977.CrossRefPubMed Moradkhani A, Kerwin L, Dudley-Brown S, Tabibian JH. Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease. Dig Dis Sci. 2011;56:2972–2977.CrossRefPubMed
10.
go back to reference Ashok K, Mathew A, Thomas A, Mohan D, Gopalakrishna R, Reghu R. Clinical Pharmacist’s Interventions on Medication Adherence and Knowledge of Inflammatory Bowel Disease Patients. J Young Pharm. 2017;9:381–385.CrossRef Ashok K, Mathew A, Thomas A, Mohan D, Gopalakrishna R, Reghu R. Clinical Pharmacist’s Interventions on Medication Adherence and Knowledge of Inflammatory Bowel Disease Patients. J Young Pharm. 2017;9:381–385.CrossRef
11.
go back to reference Červený LP, Bortlík LM, Kuběna LA, Vlček LJ, Lakatos LP, Lukáš LM. Nonadherence in inflammatory bowel disease: Results of factor analysis. Inflamm Bowel Dis. 2007;13:1244–1249.CrossRefPubMed Červený LP, Bortlík LM, Kuběna LA, Vlček LJ, Lakatos LP, Lukáš LM. Nonadherence in inflammatory bowel disease: Results of factor analysis. Inflamm Bowel Dis. 2007;13:1244–1249.CrossRefPubMed
12.
go back to reference Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:615–622.CrossRefPubMed Colombara F, Martinato M, Girardin G, Gregori D. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:615–622.CrossRefPubMed
13.
go back to reference Panés J, O’Connor M, Peyrin-Biroulet L, Irving P, Petersson J, Colombel J-F. Improving quality of care in inflammatory bowel disease: What changes can be made today? J Crohns Colitis. 2014;8:919–926.CrossRefPubMed Panés J, O’Connor M, Peyrin-Biroulet L, Irving P, Petersson J, Colombel J-F. Improving quality of care in inflammatory bowel disease: What changes can be made today? J Crohns Colitis. 2014;8:919–926.CrossRefPubMed
14.
go back to reference Kesavarapu K, Zelenkauskaite A, Nandi N. Reach and Power of Physician-Initiated Tweets in a Twitter Inflammatory Bowel Disease Community. Crohns Colitis 360. 2021;3:otab052. Kesavarapu K, Zelenkauskaite A, Nandi N. Reach and Power of Physician-Initiated Tweets in a Twitter Inflammatory Bowel Disease Community. Crohns Colitis 360. 2021;3:otab052.
15.
go back to reference Alharbi R, Almahmudi F, Makhdoom Y, Mosli M. Knowledge and attitudes of primary healthcare physicians toward the diagnosis and management of inflammatory bowel disease following an educational intervention: A comparative analysis. Saudi J Gastroenterol. 2019;25:277–285.CrossRefPubMedPubMedCentral Alharbi R, Almahmudi F, Makhdoom Y, Mosli M. Knowledge and attitudes of primary healthcare physicians toward the diagnosis and management of inflammatory bowel disease following an educational intervention: A comparative analysis. Saudi J Gastroenterol. 2019;25:277–285.CrossRefPubMedPubMedCentral
16.
go back to reference Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;17:590–598.CrossRef Bernstein KI, Promislow S, Carr R, Rawsthorne P, Walker JR, Bernstein CN. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;17:590–598.CrossRef
17.
go back to reference Yoon H, Yang S-K, So H et al. Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease. Korean J Intern Med. 2019;34:81–89.CrossRefPubMed Yoon H, Yang S-K, So H et al. Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease. Korean J Intern Med. 2019;34:81–89.CrossRefPubMed
18.
go back to reference Catalán-Serra I, Huguet-Malavés JM, Mínguez M et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterol Hepatol. 2015;38:355–363.CrossRefPubMed Catalán-Serra I, Huguet-Malavés JM, Mínguez M et al. Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps. Gastroenterol Hepatol. 2015;38:355–363.CrossRefPubMed
19.
go back to reference Kim JY, Yoon H, Hwang JS, Yang S-K, Park SH, Loftus EV. Comparison of Disease-related Knowledge of Patients With Inflammatory Bowel Disease Between the West and the East Using an Updated Questionnaire (IBD-KNOW). J Clin Gastroenterol. 2020;54:720–724.CrossRefPubMed Kim JY, Yoon H, Hwang JS, Yang S-K, Park SH, Loftus EV. Comparison of Disease-related Knowledge of Patients With Inflammatory Bowel Disease Between the West and the East Using an Updated Questionnaire (IBD-KNOW). J Clin Gastroenterol. 2020;54:720–724.CrossRefPubMed
20.
go back to reference Feeney M, Chur-Hansen A, Mikocka-Walus A. People Living with Inflammatory Bowel Disease Want Multidisciplinary Healthcare: A Qualitative Content Analysis. J Clin Psychol Med Settings. 2022;29:570–577.CrossRefPubMed Feeney M, Chur-Hansen A, Mikocka-Walus A. People Living with Inflammatory Bowel Disease Want Multidisciplinary Healthcare: A Qualitative Content Analysis. J Clin Psychol Med Settings. 2022;29:570–577.CrossRefPubMed
21.
go back to reference Sephton ML, Tattersall S, Kemp K, et al. A Comparison of Gastroenterology and Non-Gastroenterology Nurses Knowledge of Inflammatory Bowel Disease. Gastroenterol. 2013;144:S-570. Sephton ML, Tattersall S, Kemp K, et al. A Comparison of Gastroenterology and Non-Gastroenterology Nurses Knowledge of Inflammatory Bowel Disease. Gastroenterol. 2013;144:S-570.
22.
go back to reference Berry AC, Mestas L, Duffy A et al. Assessment of Inflammatory Bowel Disease Knowledge Across an Academic Nursing Facility: 615. Am J Gastroenterol. 2016;111:S282–S284.CrossRef Berry AC, Mestas L, Duffy A et al. Assessment of Inflammatory Bowel Disease Knowledge Across an Academic Nursing Facility: 615. Am J Gastroenterol. 2016;111:S282–S284.CrossRef
23.
go back to reference Prasad SS, Walker MM, Talley NJ, et al. Healthcare Needs and Perceptions of People Living With Inflammatory Bowel Disease in Australia: A Mixed-Methods Study. Crohns Colitis 360. 2022;4:otab084. Prasad SS, Walker MM, Talley NJ, et al. Healthcare Needs and Perceptions of People Living With Inflammatory Bowel Disease in Australia: A Mixed-Methods Study. Crohns Colitis 360. 2022;4:otab084.
24.
go back to reference Kashkooli SB, Andrews JM, Roberts MB, Selinger CP, Leong RW. Inflammatory bowel disease-specific pregnancy knowledge of gastroenterologists against general practitioners and obstetricians. United European Gastroenterol J. 2015;3:462.CrossRefPubMedPubMedCentral Kashkooli SB, Andrews JM, Roberts MB, Selinger CP, Leong RW. Inflammatory bowel disease-specific pregnancy knowledge of gastroenterologists against general practitioners and obstetricians. United European Gastroenterol J. 2015;3:462.CrossRefPubMedPubMedCentral
25.
go back to reference Vernon-Roberts A, Otley A, Frampton C, Gearry RB, Day AS. Validation of a Revised Knowledge Assessment Tool for Children with Inflammatory Bowel Disease (IBD-KID2). Inflamm Intest Dis. 2020;5:70–77.CrossRefPubMedPubMedCentral Vernon-Roberts A, Otley A, Frampton C, Gearry RB, Day AS. Validation of a Revised Knowledge Assessment Tool for Children with Inflammatory Bowel Disease (IBD-KID2). Inflamm Intest Dis. 2020;5:70–77.CrossRefPubMedPubMedCentral
26.
go back to reference Vernon-Roberts A, Otley A, Frampton C, Gearry RB, Day AS. Response pattern analysis of IBD-KID: A knowledge assessment tool for children with inflammatory bowel disease. J Paediatr Child Health. 2019;55. Vernon-Roberts A, Otley A, Frampton C, Gearry RB, Day AS. Response pattern analysis of IBD-KID: A knowledge assessment tool for children with inflammatory bowel disease. J Paediatr Child Health. 2019;55.
27.
go back to reference Buerkle K, Vernon-Roberts A, Ho C, Schultz M, Day A. A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease. Dig Dis Sci. 2022;67:2049–2058.CrossRefPubMedPubMedCentral Buerkle K, Vernon-Roberts A, Ho C, Schultz M, Day A. A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease. Dig Dis Sci. 2022;67:2049–2058.CrossRefPubMedPubMedCentral
29.
go back to reference Vernon-Roberts A, Gearry R, Day A. Assessment of knowledge levels following an education program for parents of children with inflammatory bowel disease. Front Pediatr. 2020;8. Vernon-Roberts A, Gearry R, Day A. Assessment of knowledge levels following an education program for parents of children with inflammatory bowel disease. Front Pediatr. 2020;8.
30.
go back to reference Vernon-Roberts A, Gearry R, Day A. The level of public knowledge regarding inflammatory bowel disease in Christchurch. New Zealand. Inflamm Intest Dis. 2020;5:205–211.CrossRefPubMed Vernon-Roberts A, Gearry R, Day A. The level of public knowledge regarding inflammatory bowel disease in Christchurch. New Zealand. Inflamm Intest Dis. 2020;5:205–211.CrossRefPubMed
31.
go back to reference Afra B, Alizadeh M, Taghavi S, Bayrami HJ, Yari J. The Impact of Early Clinical Exposure on the Knowledge and Attitude of Basic Sciences Medical Students at Tabriz University of Medical Sciences. Research and Development in Medical Education. 2015;4:55–60.CrossRef Afra B, Alizadeh M, Taghavi S, Bayrami HJ, Yari J. The Impact of Early Clinical Exposure on the Knowledge and Attitude of Basic Sciences Medical Students at Tabriz University of Medical Sciences. Research and Development in Medical Education. 2015;4:55–60.CrossRef
32.
go back to reference Park JA, Safer JD. Clinical Exposure to Transgender Medicine Improves Students’ Preparedness Above Levels Seen with Didactic Teaching Alone: A Key Addition to the Boston University Model for Teaching Transgender Healthcare. Transgend Health. 2018;3:10–16.CrossRefPubMedPubMedCentral Park JA, Safer JD. Clinical Exposure to Transgender Medicine Improves Students’ Preparedness Above Levels Seen with Didactic Teaching Alone: A Key Addition to the Boston University Model for Teaching Transgender Healthcare. Transgend Health. 2018;3:10–16.CrossRefPubMedPubMedCentral
33.
go back to reference Nanaware NL, Gavkare AM. Impact of early clinical exposure to boost applicative aspects of learning in first MBBS physiology students. Natl J Physiol Pharm Pharmacol. 2020;10:141–143. Nanaware NL, Gavkare AM. Impact of early clinical exposure to boost applicative aspects of learning in first MBBS physiology students. Natl J Physiol Pharm Pharmacol. 2020;10:141–143.
34.
go back to reference Prasad SS, Keely S, Talley NJ, et al. Primary care pharmacists’ knowledge and perception of Inflammatory Bowel Disease: a cross-sectional study in Australia. Health Education in Practice: Journal of Research for Professional Learning. 2022;5. Prasad SS, Keely S, Talley NJ, et al. Primary care pharmacists’ knowledge and perception of Inflammatory Bowel Disease: a cross-sectional study in Australia. Health Education in Practice: Journal of Research for Professional Learning. 2022;5.
35.
go back to reference Tinsley A, Ehrlich OG, Hwang C et al. Knowledge, Attitudes, and Beliefs Regarding the Role of Nutrition in IBD Among Patients and Providers. Inflamm Bowel Dis. 2016;22:2474–2481.CrossRefPubMed Tinsley A, Ehrlich OG, Hwang C et al. Knowledge, Attitudes, and Beliefs Regarding the Role of Nutrition in IBD Among Patients and Providers. Inflamm Bowel Dis. 2016;22:2474–2481.CrossRefPubMed
36.
go back to reference Crooks B, McLaughlin J, Limdi J. Dietary beliefs and recommendations in inflammatory bowel disease: a national survey of healthcare professionals in the UK. Frontline Gastroenterol. 2022;13:25–31.CrossRefPubMed Crooks B, McLaughlin J, Limdi J. Dietary beliefs and recommendations in inflammatory bowel disease: a national survey of healthcare professionals in the UK. Frontline Gastroenterol. 2022;13:25–31.CrossRefPubMed
37.
go back to reference Kamp KJ, Pennings B, Javelli D, Wyatt G, Given B. Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross-sectional study. J Hum Nutr Diet. 2021;34:257–264.CrossRefPubMed Kamp KJ, Pennings B, Javelli D, Wyatt G, Given B. Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross-sectional study. J Hum Nutr Diet. 2021;34:257–264.CrossRefPubMed
38.
go back to reference Zallot C, Quilliot D, Chevaux J-B et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19:66–72.CrossRefPubMed Zallot C, Quilliot D, Chevaux J-B et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19:66–72.CrossRefPubMed
39.
go back to reference Marsh A, Kinneally J, Robertson T, Lord A, Young A, Radford –Smith G. Food avoidance in outpatients with Inflammatory Bowel Disease – Who, what and why. Clin Nutr ESPEN. 2019;31:10–6. Marsh A, Kinneally J, Robertson T, Lord A, Young A, Radford –Smith G. Food avoidance in outpatients with Inflammatory Bowel Disease – Who, what and why. Clin Nutr ESPEN. 2019;31:10–6.
40.
go back to reference Lamers CR, de Roos NM, Witteman BJM. The association between inflammatory potential of diet and disease activity: results from a cross-sectional study in patients with inflammatory bowel disease. BMC Gastroenterology. 2020;20:316.CrossRefPubMedPubMedCentral Lamers CR, de Roos NM, Witteman BJM. The association between inflammatory potential of diet and disease activity: results from a cross-sectional study in patients with inflammatory bowel disease. BMC Gastroenterology. 2020;20:316.CrossRefPubMedPubMedCentral
42.
go back to reference Brown SC, Whelan K, Frampton C, Wall CL, Gearry RB, Day AS. Food-Related Quality of Life in Children and Adolescents With Crohn’s Disease. Inflamm Bowel Dis. 2022:izac010. Brown SC, Whelan K, Frampton C, Wall CL, Gearry RB, Day AS. Food-Related Quality of Life in Children and Adolescents With Crohn’s Disease. Inflamm Bowel Dis. 2022:izac010.
43.
go back to reference Cox SR, Clarke H, O’Keeffe M et al. Nutrient, Fibre, and FODMAP Intakes and Food-related Quality of Life in Patients with Inflammatory Bowel Disease, and Their Relationship with Gastrointestinal Symptoms of Differing Aetiologies. J Crohns Colitis. 2021;15:2041–2053.CrossRefPubMedPubMedCentral Cox SR, Clarke H, O’Keeffe M et al. Nutrient, Fibre, and FODMAP Intakes and Food-related Quality of Life in Patients with Inflammatory Bowel Disease, and Their Relationship with Gastrointestinal Symptoms of Differing Aetiologies. J Crohns Colitis. 2021;15:2041–2053.CrossRefPubMedPubMedCentral
44.
go back to reference Jennifer L, Michele R. Intensive IBD Educational Program to Increase Staff Nurse Knowledge. Inflamm Bowel Dis. 2014;20:S87–S88.CrossRef Jennifer L, Michele R. Intensive IBD Educational Program to Increase Staff Nurse Knowledge. Inflamm Bowel Dis. 2014;20:S87–S88.CrossRef
45.
go back to reference Kim ES, Kwon KT, Kim SK et al. Impact of Education on School Nurses’ Knowledge of Inflammatory Bowel Disease. Gut Liver. 2019;13:48–53.CrossRefPubMed Kim ES, Kwon KT, Kim SK et al. Impact of Education on School Nurses’ Knowledge of Inflammatory Bowel Disease. Gut Liver. 2019;13:48–53.CrossRefPubMed
46.
go back to reference Lubarda J, Braun R, Hanauer SB. Impact of Online Continuing Medical Education on Physician Knowledge of Pathogenesis and Biologic Therapies in Inflammatory Bowel Disease. Am J Gastroenterol. 2015;110:S795.CrossRef Lubarda J, Braun R, Hanauer SB. Impact of Online Continuing Medical Education on Physician Knowledge of Pathogenesis and Biologic Therapies in Inflammatory Bowel Disease. Am J Gastroenterol. 2015;110:S795.CrossRef
47.
go back to reference Charabaty A, Bilal M, Kickel A, et al. Twitter-based educational activities #mondaynightibd and #scopingsundays enhance engagement in learning, improve clinical practice, and facilitate networking and collaboration among members of the gastroenterology community. Gastroenterol. 2021;160:S-582. Charabaty A, Bilal M, Kickel A, et al. Twitter-based educational activities #mondaynightibd and #scopingsundays enhance engagement in learning, improve clinical practice, and facilitate networking and collaboration among members of the gastroenterology community. Gastroenterol. 2021;160:S-582.
48.
go back to reference Facanali MRJ, Bortolozzo Graciolli Facanali C, Queiroz NSF, Sobrado CWJ, Nahas SC, Safatle-Ribeiro AV. #Crohn’s: Historical Cohort of Twitter Activity. Crohns Colitis 360. 2021;3:otaa075. Facanali MRJ, Bortolozzo Graciolli Facanali C, Queiroz NSF, Sobrado CWJ, Nahas SC, Safatle-Ribeiro AV. #Crohn’s: Historical Cohort of Twitter Activity. Crohns Colitis 360. 2021;3:otaa075.
49.
go back to reference Prasad SS, Keely S, Talley NJ, Kairuz T, Walker MM. Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease. Pharmacy. 2020;8:68.CrossRefPubMedPubMedCentral Prasad SS, Keely S, Talley NJ, Kairuz T, Walker MM. Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease. Pharmacy. 2020;8:68.CrossRefPubMedPubMedCentral
50.
go back to reference Prasad SS, Duncanson K, Keely S, et al. A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review. Pharmacy (Basel). 2020;8. Prasad SS, Duncanson K, Keely S, et al. A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review. Pharmacy (Basel). 2020;8.
51.
go back to reference Alrashed F, Almutairi N, Shehab M. The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction. Healthcare. 2022;10:1818.CrossRefPubMedPubMedCentral Alrashed F, Almutairi N, Shehab M. The Role of Clinical Pharmacists in Improving Quality of Care in Patients with Inflammatory Bowel Disease: An Evaluation of Patients’ and Physicians’ Satisfaction. Healthcare. 2022;10:1818.CrossRefPubMedPubMedCentral
Metadata
Title
Knowledge Levels About Inflammatory Bowel Disease Vary Between Healthcare Professional Groups
Authors
Angharad Vernon-Roberts
Lucy Blay
Andrew S. Day
Publication date
12-12-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08191-x

Other articles of this Issue 2/2024

Digestive Diseases and Sciences 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.